Table 3.

Types of pharmacotherapy recommended in national guidelines for smoking cessation in primary care

	Argentina	Australia	Canadaa	Chile	Czech Republic	Denmark	France	Germany	India	Japan	Jordan	Kyrgyzstan	Malaysia	Netherlands	New Zealand	Norway	Portugal	Scotlandb	South Africa	Sweden	UK	USA
NRT	✓	✓		✓	✓	✓	✓	✓	✓	✓	✓	✓	✓	✓	✓	✓	✓		✓	✓	✓	✓
Bupropion	✓	✓		✓	✓	✓	✓	✓	✓	✓		✓	✓	✓	✓	✓	✓			✓	✓	✓
Varenicline	✓	✓			✓	✓	✓	✓	✓	✓			✓		✓		✓		✓	✓	✓	✓
Combination NRT	✓	✓		✓	✓	✓	✓	✓		✓	✓	✓	✓	✓	✓	✓	✓		✓	✓	✓	✓
Combined NRT + Bupropion	✓			✓	✓			✓			✓		✓	✓					✓			✓
Nortriptyline	✓c	✓c						✓			✓c			✓	✓		✓		✓			✓c
Clonidine	✓c										✓c						✓c					✓c

Note: NRT nicotine replacement therapy.

Excluding guidelines targeting specific populations

^aThe Canadian guideline did not include a section of recommendations regarding pharmacotherapy. It was noted within these guideline that the development of these recommendations was in progress. At the time of writing this paper an update including recommendations for pharmacotherapy had not been released

^bThe Scottish guidelines did include recommendations for pharmacotherapy, however, these were included within recommendations for Specialist Stop Smoking Services which were not extracted for the purpose of this review. These recommended NRT, combination NRT and bupropion

^cSecond line